Skip to main content

Advertisement

Log in

Preliminary safety and efficacy results of laser immunotherapy for the treatment of metastatic breast cancer patients

  • Paper
  • Published:
Photochemical & Photobiological Sciences Aims and scope Submit manuscript

Abstract

We report our preliminary results of a pilot clinical trial of late-stage breast cancer patients treated by laser immunotherapy (LIT), a local intervention using an 805 nm laser for non-invasive irradiation, indocyanine green for selective thermal effect, and immunoadjuvant (glycated chitosan) for immunological stimulation. Ten breast cancer patients were enrolled in this study; all patients were considered to be out of other available treatment options. Toxicity was individually evaluated through physical exams and laboratory tests. Adverse reactions only occurred in the area of treatment due to photothermal injury and local administration of immunoadjuvant. No grade 3 or 4 side effects were observed. Treatment efficacy of LIT was also evaluated by physical examination and tomography. In 8 patients available for evaluation, the objective response rate was 62.5% and the clinical beneficial response rate was 75%. While the study is still ongoing, the initial outcomes of this clinical trial show that LIT is well tolerated and is promising in the treatment of metastatic breast cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. O. J. Finn, N. Engl. J. Med., 2008, 358, 2704–2715.

    Article  CAS  Google Scholar 

  2. T. A. Waldmann, Nat. Med., 2003, 9, 269–277.

    Article  CAS  Google Scholar 

  3. J. W. Simons, M. A. Carducci, B. Mikhak, M. Lim, B. Biedrzycki, F. Borellini, S. M. Clift, K. M. Hege, D. G. Ando, S. Piantadosi, R. Mulligan and W. G. Nelson, Clin. Cancer Res., 2006, 12, 3394–3401.

    Article  CAS  Google Scholar 

  4. E. J. Small, N. Sacks, J. Nemunaitis, W. J. Urba, E. Dula, A. S. Centeno, W. G. Nelson, D. Ando, C. Howard, F. Borellini, M. Nguyen, K. Hege and J. W. Simons, Clin. Cancer Res., 2007, 13, 3883–3891.

    Article  CAS  Google Scholar 

  5. I. Komenaka, H. Hoerig and L. Kaufman, Clin. Dermatol., 2004, 22, 251–265.

    Article  Google Scholar 

  6. W. R. Chen, R. L. Adams, R. Carubelli and R. E. Nordquist, Cancer Lett., 1997, 115, 25–30.

    Article  CAS  Google Scholar 

  7. W. R. Chen, R. Carubelli, H. Liu and R. E. Nordquist, Mol. Biotechnol., 2003, 25, 37–43.

    Article  CAS  Google Scholar 

  8. W. R. Chen, H. Liu, J. W. Ritchey, K. E. Bartels, M. D. Lucroy and R. E. Nordquist, Cancer Res., 2002, 62, 4295–4299.

    CAS  PubMed  Google Scholar 

  9. S. Song, F. Zhou, R. E. Nordquist, R. Carubelli, H. Liu and W. R. Chen, Immunopharmacol. Immunotoxicol., 2009, 31, 202–208.

    Article  CAS  Google Scholar 

  10. W. R. Chen, S. W. Jeong, M. D. Lucroy, R. F. Wolf, E. W. Howard, H. Liu and R. E. Nordquist, Int. J. Cancer, 2003, 107, 1053–1057.

    Article  CAS  Google Scholar 

  11. W. R. Chen, W. G. Zhu, J. R. Dynlacht, H. Liu and R. E. Nordquist, Int. J. Cancer, 1999, 81, 808–812.

    Article  CAS  Google Scholar 

  12. W. R. Chen, A. K. Singhal, H. Liu and R. E. Nordquist, Cancer Res., 2001, 61, 459–461.

    CAS  PubMed  Google Scholar 

  13. S. E. Singletary and J. L. Connolly, Ca-Cancer J. Clin., 2006, 56, 37–47.

    Article  Google Scholar 

  14. US Department of Health and Human Services, National Institutes of Health, National Cancer Institute, Cancer Therapy Evaluation Program, Division of Cancer Treatment and Diagnosis: Common terminology criteria for adverse events v3.0 (CTCAE). Available: http://ctep.cancer.gov/protocolDevelopment/electronic_applications/docs/ctcaev3.pdf [accessed September 28, 2009].

    Google Scholar 

  15. J. D. Wolchok, A. Hoos, S. O’Day, J. S. Weber, O. Hamid, C. Lebbé, M. Maio, M. Binder, O. Bohnsack, G. Nichol, R. Humphrey and F. S. Hodi, Clin. Cancer Res., 2009, 15, 7412–7420.

    Article  CAS  Google Scholar 

  16. S. Martin, M. Mannino, A. Rostom, D. Tait, E. Donovan, S. Eagle, J. Haviland and J. Yarnold, Clin. Oncol. (R. Coll. Radiol.), 2008, 20, 502–505.

    Article  CAS  Google Scholar 

  17. R. Keskikuru, A. Jukkola, J. Nuutinen, V. Kataja, J. Risteli, P. Autio and T. Lahtinen, Radiother. Oncol., 2004, 70, 243–248.

    Article  CAS  Google Scholar 

  18. G. Viale and L. Bottiglieri, Eur. J. Cancer, 2009, 45(Suppl 1), 5–10.

    Article  Google Scholar 

  19. S. Y. Jung, H. Y. Kim, B. H. Nam, S. Y. Min, S. J. Lee, C. Park, Y. Kwon, E. A. Kim, K. L. Ko, K. H. Shin, K. S. Lee, I. H. Park, S. Lee, S. W. Kim, H. S. Kang and J. Ro, Breast Cancer Res. Treat., 2010, 120, 627–637.

    Article  Google Scholar 

  20. E. A. Perez, A. Moreno-Aspitia, E. Aubrey Thompson and C. A. Andorfer, Breast Cancer Res. Treat., 2010, 120, 285–291.

    Article  CAS  Google Scholar 

  21. E. Jäger, D. Jäger and A. Knuth, Int. J. Cancer, 2003, 106, 817–820.

    Article  Google Scholar 

  22. M. H. den Brok, R. P. Sutmuller, R. Van Der Voort, E. J. Bennink, C. G. Figdor, T. J. Ruers and G. J. Adema, Cancer Res., 2004, 64, 4024–4029.

    Article  Google Scholar 

  23. H. G. Zhang, K. Mehta, P. Cohen and C. Guha, Cancer Lett., 2008, 271, 191–204.

    Article  CAS  Google Scholar 

  24. V. Milani and E. Noessner, Cancer Immunol. Immunother., 2005, 55, 312–319.

    Article  Google Scholar 

  25. S. Koido, E. Hara, S. Homma, K. Fujise, J. Gong and H. Tajiri, Arch. Immunol. Ther. Exp., 2007, 55, 281–287.

    Article  CAS  Google Scholar 

  26. A. Mukhopadhaya, J. Mendecki, X. Dong, L. Liu, S. Kalnicki, M. Garg, A. Alfieri and C. Guha, Cancer Res., 2007, 67, 7798–7806.

    Article  CAS  Google Scholar 

  27. J. Guo, J. Zhu, X. Sheng, X. Wang, L. Qu, Y. Han, Y. Liu, H. Zhang, L. Huo, S. Zhang, B. Lin and Z. Yang, Int. J. Cancer, 2007, 120, 2418–2425.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Wei R. Chen.

Additional information

This article is published as part of a themed issue on immunological aspects and drug delivery technologies in PDT.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Li, X., Ferrel, G.L., Guerra, M.C. et al. Preliminary safety and efficacy results of laser immunotherapy for the treatment of metastatic breast cancer patients. Photochem Photobiol Sci 10, 817–821 (2011). https://doi.org/10.1039/c0pp00306a

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1039/c0pp00306a

Navigation